Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease

平台已收录预计检索 <10 秒

查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。

文献信息

题目: Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
作者: Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock, Mark B. Carlton
发表年份: 2021
期刊 / 来源: The Journal of Pharmacology and Experimental Therapeutics
出版社: American Society for Pharmacology and Experimental Therapeutics
DOI: 10.1124/jpet.120.000438
文献类型: 学术文献
平台记录更新: 2026-10-09 17:01:37

本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。